AI startup Somite raises $47m to revolutionize stem cell therapy
Longevity Technology - 16-May-2025Somite AI uses DeltaStem to speed up and scale stem cell engineering
Join the club for FREE to access the whole archive and other member benefits.
Founder and CEO of Somite.ai
Dr. Micha Breakstone is a serial entrepreneur and AI innovator, currently serving as the founder and CEO of Somite.ai, a biotech startup leveraging artificial intelligence to advance stem cell therapies. Prior to this, he co-founded Chorus.ai, a conversation intelligence platform acquired by ZoomInfo for $575 million, and NeuraLight.ai, which secured over $30 million in funding within its first year.
Dr. Breakstone's academic background includes a Master's degree in Mathematics and a Ph.D. in Cognitive Science. He has a strong passion for the intersection of language and algorithms, believing that enhancing natural language processing technologies is crucial for empowering humans through AI.
Visit website: https://www.michabreakstone.com/
See alsoDetails last updated 18-May-2025
Somite AI uses DeltaStem to speed up and scale stem cell engineering